Discovery of 2-(2-benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGlu₅): from an artificial neural network virtual screen to an in vivo tool compound. Academic Article uri icon

Overview

publication date

  • January 20, 2012

Research

keywords

  • Anxiety Disorders
  • Benzoxazoles
  • Brain
  • Psychotropic Drugs
  • Pyrimidines
  • Receptors, Metabotropic Glutamate

Identity

PubMed Central ID

  • PMC3517057

Scopus Document Identifier

  • 84857732011

Digital Object Identifier (DOI)

  • 10.1002/cmdc.201100510

PubMed ID

  • 22267125

Additional Document Info

volume

  • 7

issue

  • 3